Brewer Sports International (BSI), a multi-faceted global sports
advisory firm, and Amarantus BioScience Holdings, Inc.
(OTCQB:AMBS), a biotechnology company focused on the discovery and
development of novel diagnostics and therapeutics related to cell
cycle dysregulation, endoplasmic reticulum stress,
neurodegeneration and apoptosis, are pleased to provide an update
surrounding the 3rd Alzheimer's focused #C4CT (Coalition for
Concussion Treatment) Concussion Awareness Summit, powered by MDM
Worldwide on Thursday, July 31, 2014 at the United Nations in New
York City, NY.
"The concussion crisis has changed the face of sports as we know
it and it has brought to surface the incredible importance of our
brain health. The time is now for us to make our brain the number
one priority so that education and awareness can take effect, and
begin to change the way we approach the health of our athletes from
youth to professionals." - Ben Utecht
Below is a list of prestigious participants from the sports
field, including former professional athletes, broadcasters and
other key stakeholders for the #C4CT Concussion Awareness
Summit.
- Andrea Kremer, Chief Correspondent for Player
Health and Safety at the NFL Network
- Andrew Brandt, NFL Business Analyst for
ESPN
- Sidney Rice, NFL Pro Bowler, Super Bowl
Champion
- Ben Utecht, NFL Super Bowl Champion, Recording
Artist, Motivational Speaker, and National Concussion and Brain
Disease Advocate, Recipient of 2014 PLINA Award (Public Leadership
In Neurology Award)
- Chris Nowinski, Co-Founder and Executive
Director of Sports Legacy Institute; Co-Director for the Center of
the Study of Traumatic Encephalopathy at Boston University, School
of Medicine; Former WWE Wrestler
- Clinton Portis, 2X NFL Pro Bowler, Former NFL
Running Back
- Darrell Reid, NFL Super Bowl Champion, Former
NFL Linebacker
To register or for additional information, please visit
www.c4ctsummit.com. For further event questions, please contact
Lindsay Lommel at lindsay.lommel@thebrewergroup.com. For
sponsorship information please visit:
www.c4ctsummit.com/sponsorship-opportunities.
The #C4CT Concussion Awareness Summit is being convened on July
31, 2014 to explore the potential link between TBI and Alzheimer's
disease. A diverse working group of clinicians, medical
researchers, policy makers, international diplomats, athletes,
celebrities, and philanthropic organizations will be assembled to
raise awareness, advance clinical research, and develop public
policy in order to address this major unmet medical need and public
health issue. The #C4CT Summit will webcast live and on-demand and
will be available on the UN Web TV website
at: http://webtv.un.org.
BSI and AMBS would like to thank Dominion Capital, Cavendish
Global, and One Mind for their continued support and unparalleled
contributions which make this event possible.
About Amarantus BioScience Holdings, Inc.
Amarantus BioScience Holdings (AMBS) is a biotechnology company
developing treatments and diagnostics for diseases associated with
neurodegeneration and protein misfolding-related apoptosis. AMBS
has licensed Eltoprazine ("Eltoprazine"), a phase 2b ready
indication for Parkinson's Levodopa induced dyskinesia and Adult
ADHD. AMBS has an exclusive worldwide license to the Lymphocyte
Proliferation test ("LymPro Test(R)") for Alzheimer's disease and
owns the intellectual property rights to a therapeutic protein
known as Mesencephalic-Astrocyte-derived Neurotrophic Factor
("MANF") and is developing MANF-based products as treatments for
brain disorders. AMBS also owns intellectual property for the
diagnosis of Parkinson's disease ("NuroPro") and the discovery of
neurotrophic factors ("PhenoGuard"). Amarantus operations are
located at Janssen Labs @QB3 in San Francisco, CA. For further
information please visit www.Amarantus.com, or connect with the
Company on Facebook, LinkedIn, Twitter and Google+.
About Brewer Sports International
Founded by international entrepreneur Jack Brewer, five-year
National Football League (NFL) veteran and former three-team
captain, Brewer Sports International (BSI) is a multi-faceted
global sports advisory firm within The Brewer Group Companies with
a focus on the business of sport and wellness for professional
athletes, sports agencies, public and private corporations and
various partners including international organizations, governments
and NGOs. Based in Minneapolis with offices spanning the globe, BSI
offers a unique financial services platform to professional
athletes and sports agencies, as well as high-net-worth individuals
and businesses related to sports. BSI takes pride in enabling its
clients to capitalize on the endless opportunities presented
through sport. For more information, please
visitwww.brewersports.com or follow them on Facebook, Twitter and
LinkedIn.
About MDM Worldwide
MDM Worldwide Solutions, Inc. is a digital communications agency
that develops and manages online engagement strategies to connect
companies with their stakeholders. MDM specializes in working with
clients in the technology, healthcare and life sciences spaces.
MDM's vast industry knowledge, proprietary methodology, proven
track record and experienced leadership team enables them to create
and customize targeted digital marketing campaigns to fulfill all
of their clients' objectives. For more information, please visit
mdmworldwide.com or find them on Facebook, Twitter, Google+ and
LinkedIn.
Certain statements, other than purely historical information,
including estimates, projections, statements relating to our
business plans, objectives, and expected operating results, and the
assumptions upon which those statements are based, are
forward-looking statements." These forward-looking statements
generally are identified by the words believes," project,"
expects," anticipates," estimates," intends," strategy," plan,"
may," will," would," will be," will continue," will likely result,"
and similar expressions. Forward-looking statements are based on
current expectations and assumptions that are subject to risks and
uncertainties which may cause actual results to differ materially
from the forward-looking statements. Our ability to predict results
or the actual effect of future plans or strategies is inherently
uncertain. Factors which could have a material adverse effect on
our operations and future prospects on a consolidated basis
include, but are not limited to: changes in economic conditions,
legislative/regulatory changes, availability of capital, interest
rates, competition, and generally accepted accounting principles.
These risks and uncertainties should also be considered in
evaluating forward-looking statements and undue reliance should not
be placed on such statements.
CONTACT: Brewer Sports International:
Kristi Hofacker, Director of Interactive Marketing and Media
651.247.4460
kristi.hofacker@thebrewergroup.com
Amarantus Bioscience Holdings, Inc.:
Aimee Boutcher, Investor Relations
408.737.2734 x 101
ir@amarantus.com
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Apr 2023 to Apr 2024